U.S. study points to strong new class of antibiotics

CHICAGO (Reuters) - Three naturally occurring antibacterial compounds hold promise for a new class of antibiotics, offering hope for fresh weapons against infection at a time when older drugs are losing their punch, researchers said on Thursday.

The new agents, reported in the journal Cell, may even provide a quicker cure for tuberculosis, which could help people stick to the prescribed therapy better and reduce the development of resistant strains.

“The three antibiotics are attractive candidates for development as broad spectrum antibacterial agents,” said Richard Ebright of Rutgers University in New Brunswick, New Jersey.

Ebright and colleagues showed how the three antibiotic compounds — myxopyronin, corallopyronin and ripostatin — block the action of bacterial RNA polymerase, an enzyme needed by bacteria to unlock genetic information from DNA needed to make proteins.

Blocking this enzyme kills the bacteria, they said.

All three compounds are naturally produced by some bacteria for use in a kind of chemical warfare against other bacteria. The agents work by taking advantage of a design flaw in bacterial RNA polymerase.

“RNA polymerase has a shape reminiscent of a crab claw, with two prominent pincer-like projections,” Ebright said in a statement.

“Just as with a real crab claw, one pincer stays fixed and one pincer moves — opening and closing to keep DNA in place.”

All three antibiotics work by jamming the pincer hinge, keeping the bacteria from letting DNA into the enzyme. Without the needed genetic code, the bacteria cannot make proteins.  Continued…


Related Posts:

CHICAGO (Reuters) - Bleach has been killing germs for more than 200 years but U.S. scientists have just figured out how the cleaner does its dirty work. It seems that hypochlorous acid, the active ingredient in bleach, attacks proteins in bacteria, causing them to clump up much like an egg that has been boiled, a team

Full Post: Mystery solved: How bleach kills germs

By Will Dunham WASHINGTON (Reuters) - Use of antibiotics at U.S. hospitals is rising despite concerns about fueling bacterial resistance, with Wyeth’s Zosyn and the older drug vancomycin driving the trend, researchers said. Use of antibiotics at a group of U.S. academic medical centers rose 7 percent from 2002 to 2006, Ronald Polk of Virginia Commonwealth University

Full Post: Hospitals use more antibiotics despite concerns

By Julie Steenhuysen CHICAGO (Reuters) - A drug used to suppress the immune system in cancer and rheumatoid arthritis has helped extend the life of a Minnesota boy struggling with a rare and deadly form of the genetic disorder Pompe disease. A team of researchers led by Dr. Nancy Mendelsohn of Children’s Hospitals and Clinics of Minnesota

Full Post: New therapy helps boy with rare disease

LONDON (Reuters) - Giving antibiotics to patients in intensive care units as a precaution saves lives, according to a major Dutch study published Wednesday. The findings in the New England Journal of Medicine suggest the benefits of administering antibiotics right away, even before an infection develops, outweigh the risks people will develop resistance to them, the

Full Post: Antiobitics before infections save lives: study

Traveller’s diarrhoea and antibiotics, the relation and the issue, both are very controversial. There are several international travellers that support the idea of taking some antibiotics like Cipro or others to spare themselves from traveller’s diarrhoea. But, is antibiotic an apt option to be considered for traveller’s diarrhoea? Is there any risk associated with the

Full Post: Traveller’s Diarrhoea and Antibiotics

Site Navigation

Most Read



  • kinwrite.com@gmail.com